Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Povidone-iodine + bupivacaine hydrochloride + lidocaine hydrochloride + triamcinolone** is a multi-component procedural drug combination comprising an antiseptic, two amide local anesthetics, and a corticosteroid. Bupivacaine hydrochloride and lidocaine hydrochloride reversibly inhibit voltage-gated sodium channels in peripheral nerves, preventing action-potential initiation and conduction to provide local or regional anesthesia and analgesia. Triamcinolone provides glucocorticoid receptor-mediated anti-inflammatory activity, while povidone-iodine releases iodine with broad topical antimicrobial activity. The supplied context associates closely related marketed procedural kits with triamcinolone acetonide rather than triamcinolone itself; triamcinolone and triamcinolone acetonide are chemically distinct entities, so those kits are not treated as exact brand-name matches for this specified combination.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on povidone-iodine + bupivacaine hydrochloride + lidocaine hydrochloride + triamcinolone.